Other Languages
Recognized by Forbes
Top 150
America's Best Executive Recruiting Firms.
Medtech M&A may pick up after mixed start to 2024
Medtech venture capital investing rebounded in Q1
Mass layoffs are a failure of leadership
Could Medtech M&A slump change in 2024?
Analyst optimistic for rebound in 2024
The Cash Crunch
Slump in medtech VC activity continues
Orthopedic markets to return to normal this year as post-pandemic boost fades
Medical device companies are in an ‘emerging bull market,’ Jim Cramer says
Med-tech financings April 2023
Maximizing M&A Value: Avoiding Common Mistakes by Sellers
Medtech’s top R&D spenders and the projects they launched
Don't Let the Ghost of Spine Deals Past Spook Future Deals
Medtech CDMO sector poised for M&A rebound in 2023 amid ‘attractive’ targets: report
Medtech earnings highlights: Easing of macro pressures, accelerated growth in 2023
Medtech M&A outlook for 2023: Spinoffs, China exits, AI opportunities poised to spur deal rebound
Artificial intelligence could save healthcare industry $360B a year
9 Key Investor Milestones Every Med Device Developer Should Know
Digital health outlook: trends to watch in 2023
Medtech companies start 2023 on ‘optimistic’ note amid earnings forecasts, staffing: J.P. Morgan